Methods for detection of circulating cells in non-small cell lung cancer

Frontiers in Bioscience - Landmark

Volumn 19, Issue 6, 2014, Pages 896-903

  Han, Yi ^a   Su, Chongyu ^a   Liu, Zhidong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Clinical; CTCs; Diagnosis; Metastasis; Non Small Cell lung cancer; Overall survival; Patient; Prognosis; Review; Therapy; Tumor; Tumor marker

Indexed keywords

TUMOR MARKER;

BLOOD; CARCINOMA, NON-SMALL-CELL LUNG; CELL COUNT; HUMAN; LUNG NEOPLASMS; METABOLISM; OUTCOME ASSESSMENT; PATHOLOGY; PROCEDURES; PROGNOSIS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TUMOR EMBOLISM;

CARCINOMA, NON-SMALL-CELL LUNG; CELL COUNT; HUMANS; LUNG NEOPLASMS; NEOPLASTIC CELLS, CIRCULATING; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84904353729     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/4255     Document Type: Review

References (75)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J: Cancer statistics, 2008. CA Cancer J Clin 58:71-96 (2008)
2. Duffy MJ, McGowan PM, Gallagher WM: Cancer invasion and metastasis: changing views. J Pathol 214:283-293 (2008)
3. Wittekind C, Neid M: Cancer invasion and metastasis. Oncology 69 Suppl 1:14-16 (2005)
4. Hanahan D, Weinberg RA: Hallmarks of cancer: the next generation. Cell 144:646-674 (2011)
5. Chiang AC, Massague J: Molecular basis of metastasis. N Engl J Med 359:2814-2823 (2008)
6. Pantel K, Brakenhoff RH: Dissecting the metastatic cascade. Nat Rev Cancer 4:448-456 (2004)
7. Chambers AF, Groom AC, MacDonald IC: Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2:563-572 (2002)
8. Maheswaran S, Sequist LV, Nagrath S, Ulkus L: Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med 359:366-377 (2008)
9. Aguirre-Ghiso JA: Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer 7:834-846 (2007)
10. Pantel K, Alix-Panabieres C, Riethdorf S: Cancer micrometastases. Nat Rev Clin Oncol 6:339-351 (2009)
11. Aguirre-Ghiso JA: On the theory of tumor self-seeding: implications for metastasis progression in humans. Breast Cancer Res 12:304 (2010)
12. Maheswaran S, Haber DA: Circulating tumor cells: a window into cancer biology and metastasis. Curr Opin Genet Dev 20:96-99 (2010)
13. Alix-Panabieres C, Schwarzenbach H, Pantel K: Circulating tumor cells and circulating tumor DNA. Annu Rev Med 2012;63:199-215.
14. Sun YF, Yang XR, Zhou J: Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance. J Cancer Res Clin Oncol 137:1151-1173 (2011)
15. Pantel K, Alix-Panabieres C: Circulating tumour cells in cancer patients: challenges and perspectives. Trends Mol Med 16:398-406 (2010)
16. Bednarz-Knoll N, Alix-Panabieres C, Pantel K: Clinical relevance and biology of circulating tumor cells. Breast Cancer Res 13:228 (2011)
17. Das M, Riess JW, Frankel P, Schwartz E: ERCC1 expression in circulating tumor cells (CTCs) using a novel detection platform correlates with progression-free survival (PFS) in patients with metastatic non-small-cell lung cancer (NSCLC) receiving platinum chemotherapy. Lung Cancer 77:421-426 (2012)
18. Devriese LA, Bosma AJ, van de Heuvel MM, Heemsbergen W: Circulating tumor cell detection in advanced non-small cell lung cancer patients by multimarker QPCR analysis. Lung Cancer 75:242-247 (2012)
19. Wendel M, Bazhenova L, Boshuizen R, Kolatkar A, Honnatti M: Fluid biopsy for circulating tumor cell identification in patients with early-and late-stage non-small cell lung cancer: a glimpse into lung cancer biology. Phys Biol 9:016005 (2012)
20. Hofman V, Bonnetaud C, Ilie MI, Vielh P, Vignaud JM: Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker. Clin Cancer Res 17:827-835 (2011)
21. Punnoose EA, Atwal S, Liu W, Raja R, Fine BM: Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib. Clin Cancer Res 18:2391-2401 (2012)
22. Zhu WF, Li J, Yu LC, Wu Y, Tang XP: Prognostic value of EpCAM/MUC1 mRNA-positive cells in non-small cell lung cancer patients. Tumour Biol (2013)
23. Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC: Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 10:6897-6904 (2004)
24. Van't Westeinde SC, van Klaveren RJ: Screening and early detection of lung cancer. Cancer J 17:3-10 (2011)
25. Molina R, Holdenrieder S, Auge JM, Schalhorn A: Diagnostic relevance of circulating biomarkers in patients with lung cancer. Cancer Biomark 6:163-178 (2010)
26. Herbst RS, Heymach JV, Lippman SM: Lung cancer. N Engl J Med 359:1367-1380 (2008)
27. Tuveson DA, Jacks T: Modeling human lung cancer in mice: similarities and shortcomings. Oncogene 18:5318-5324 (1999)
28. Gadgeel SM: New targets in non-small cell lung cancer. Curr Oncol Rep 15:411-423 (2013)
29. Spira A, Ettinger DS: Multidisciplinary management of lung cancer. N Engl J Med 350:379-392 (2004)
30. Tsuboi M, Ohira T, Saji H, Miyajima K, Kajiwara N: The present status of postoperative adjuvant chemotherapy for completely resected non-small cell lung cancer. Ann Thorac Cardiovasc Surg 13:73-77 (2007)
31. Krebs MG, Sloane R, Priest L, Lancashire L, Hou JM: Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer. J Clin Oncol 29:1556-1563 (2011)
32. Sastre J, Maestro ML, Puente J, Veganzones S, Alfonso R: Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables. Ann Oncol 19:935-938 (2008)
33. Cristofanilli M: Circulating tumor cells, disease progression, and survival in metastatic breast cancer. Semin Oncol 33:S9-14 (2006)
34. Paget S: The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev 8:98-101 (1989)
35. Krebs MG, Hou JM, Ward TH, Blackhall FH, Dive C: Circulating tumour cells: their utility in cancer management and predicting outcomes. Ther Adv Med Oncol 2:351-365 (2010)
36. Pantel K, Brakenhoff RH, Brandt B: Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer 8:329-340 (2008)
37. Kim MY, Oskarsson T, Acharyya S, Nguyen DX: Tumor self-seeding by circulating cancer cells. Cell 139:1315-1326 (2009)
38. Pantel K, Alix-Panabieres C: Real-time Liquid Biopsy in Cancer Patients: Fact or Fiction? Cancer Res 73:6384-6388 (2013)
39. Hou JM, Greystoke A, Lancashire L, Cummings J: Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy. Am J Pathol 175:808-816 (2009)
40. Cohen SJ, Punt CJ, Iannotti N, Saidman BH, Sabbath KD: Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol 26:3213-3221 (2008)
41. Marrinucci D, Bethel K, Kolatkar A, Luttgen MS: Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers. Phys Biol 9:016003 (2012)
42. Paris PL, Kobayashi Y, Zhao Q, Zeng W, Sridharan S: Functional phenotyping and genotyping of circulating tumor cells from patients with castration resistant prostate cancer. Cancer Lett 277:164-173 (2009)
43. Allan AL, Keeney M: Circulating tumor cell analysis: technical and statistical considerations for application to the clinic. J Oncol 2010:426218 (2010).
44. Sleijfer S, Gratama JW, Sieuwerts AM, Kraan J: Circulating tumour cell detection on its way to routine diagnostic implementation? Eur J Cancer 43:2645-2650 (2007)
45. Paterlini-Brechot P, Benali NL: Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett 253:180-204 (2007)
46. Tibbe AG, Miller MC, Terstappen LW: Statistical considerations for enumeration of circulating tumor cells. Cytometry A 71:154-162 (2007)
47. Pinzani P, Salvadori B, Simi L, Bianchi S, Distante V: Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection. Hum Pathol 37:711-718 (2006)
48. Vona G, Sabile A, Louha M, Sitruk V, Romana S: Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells. Am J Pathol 156:57-63 (2000)
49. Gertler R, Rosenberg R, Fuehrer K, Dahm M, Nekarda H, Siewert JR: Detection of circulating tumor cells in blood using an optimized density gradient centrifugation. Recent Results Cancer Res 162:149-155 (2003)
50. Bischoff J, Rosenberg R, Dahm M, Janni W, Gutschow K: Minimal residual disease in bone marrow and peripheral blood of patients with metastatic breast cancer. Recent Results Cancer Res 162:135-140 (2003)
51. Rosenberg R, Gertler R, Friederichs J, Fuehrer K, Dahm M: Comparison of two density gradient centrifugation systems for the enrichment of disseminated tumor cells in blood. Cytometry 49:150-158 (2002)
52. Zheng S, Lin HK, Lu B, Williams A, Datar R: 3D microfilter device for viable circulating tumor cell (CTC) enrichment from blood. Biomed Microdevices 13:203-213 (2011)
53. Somlo G, Lau SK, Frankel P, Hsieh HB, Liu X: Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage IV breast cancer, using a novel detection technology. Breast Cancer Res Treat 128:155-163 (2011)
54. Andreopoulou E, Yang LY, Rangel KM, Reuben JM, Hsu L: Comparison of assay methods for detection of circulating tumor cells in metastatic breast cancer: AdnaGen AdnaTest BreastCancer Select/Detect versus Veridex CellSearch system. Int J Cancer 130:1590-1597 (2012)
55. Van der Auwera I, Peeters D, Benoy IH, Elst HJ, Van Laere SJ: Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT-PCR in patients with metastatic breast cancer. Br J Cancer 102:276-284 (2010)
56. Gorges TM, Tinhofer I, Drosch M, Rose L, Zollner TM: Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition. BMC Cancer 12:178 (2012)
57. Bonnomet A, Brysse A, Tachsidis A, Waltham M, Thompson EW: Epithelial-to-mesenchymal transitions and circulating tumor cells. J Mammary Gland Biol Neoplasia 15:261-273 (2010)
58. Christiansen JJ, Rajasekaran AK: Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res 66:8319-8326 (2006)
59. van de Stolpe A, Pantel K, Sleijfer S, Terstappen LW, den Toonder JM: Circulating tumor cell isolation and diagnostics: toward routine clinical use. Cancer Res 71:5955-5960 (2011)
60. Mikolajczyk SD, Millar LS, Tsinberg P, Coutts SM: Detection of EpCAM-Negative and Cytokeratin-Negative Circulating Tumor Cells in Peripheral Blood. J Oncol 2011:252361 (2011)
61. Parkinson DR, Dracopoli N, Petty BG, Compton C, Cristofanilli M: Considerations in the development of circulating tumor cell technology for clinical use. J Transl Med 10:138 (2012)
62. Fusi A, Metcalf R, Krebs M, Dive C, Blackhall F: Clinical Utility of Circulating Tumour Cell Detection in Non-Small-Cell Lung Cancer. Curr Treat Options Oncol (2013)
63. Marrinucci D, Bethel K, Luttgen M, Bruce RH: Circulating tumor cells from well-differentiated lung adenocarcinoma retain cytomorphologic features of primary tumor type. Arch Pathol Lab Med 133:1468-1471 (2009)
64. Cho EH, Wendel M, Luttgen M, Yoshioka C, Marrinucci D: Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors. Phys Biol 9:016001 (2012)
65. Fehm T, Sagalowsky A, Clifford E, Beitsch P, Saboorian H: Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clin Cancer Res;8:2073-2084 (2002)
66. Watson MA, Ylagan LR, Trinkaus KM, Gillanders WE, Naughton MJ: Isolation and molecular profiling of bone marrow micrometastases identifies TWIST1 as a marker of early tumor relapse in breast cancer patients. Clin Cancer Res 13:5001-5009 (2007)
67. Smirnov DA, Zweitzig DR, Foulk BW, Miller MC: Global gene expression profiling of circulating tumor cells. Cancer Res 65:4993-4997 (2005)
68. Molloy TJ, Devriese LA, Helgason HH, Bosma AJ, Hauptmann M: A multimarker QPCR-based platform for the detection of circulating tumour cells in patients with early-stage breast cancer. Br J Cancer 104:1913-1919 (2011)
69. Graves H, Czerniecki BJ: Circulating tumor cells in breast cancer patients: an evolving role in patient prognosis and disease progression. Patholog Res Int 2011:621090 (2011)
70. Nieva J, Wendel M, Luttgen MS, Marrinucci D, Bazhenova L: High-definition imaging of circulating tumor cells and associated cellular events in non-small cell lung cancer patients: a longitudinal analysis. Phys Biol 9:016004 (2012)
71. Nagrath S, Sequist LV, Maheswaran S, Bell DW, Irimia D: Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450:1235-1239 (2007)
72. Krebs MG, Hou JM, Sloane R, Lancashire L, Priest L: Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches. J Thorac Oncol 7:306-315 (2012)
73. Boshuizen R, Kuhn P, van den Heuvel M: Circulating tumor cells in non-small cell lung carcinoma. J Thorac Dis 4:456-458 (2012)
74. Tanaka F, Yoneda K, Kondo N, Hashimoto M, Takuwa T: Circulating tumor cell as a diagnostic marker in primary lung cancer. Clin Cancer Res 15:6980-6986 (2009)
75. Sequist LV, Bell DW, Lynch TJ, Haber DA: Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer: J Clin Oncol 25:587-595 (2007)